- Home
- ARWR vs HOG Comparison
ARWR vs HOG Comparison
Compare ARWR & HOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- HOG
- Stock Information
- Founded
- ARWR 2003
- HOG 1903
- Country
- ARWR United States
- HOG United States
- Employees
- ARWR N/A
- HOG N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- HOG Motor Vehicles
- Sector
- ARWR Health Care
- HOG Consumer Discretionary
- Exchange
- ARWR Nasdaq
- HOG Nasdaq
- Market Cap
- ARWR 2.5B
- HOG 2.8B
- IPO Year
- ARWR 1993
- HOG N/A
- Fundamental
- Price
- ARWR $36.64
- HOG $26.68
- Analyst Decision
- ARWR Strong Buy
- HOG Buy
- Analyst Count
- ARWR 8
- HOG 7
- Target Price
- ARWR $47.75
- HOG $30.00
- AVG Volume (30 Days)
- ARWR 2.4M
- HOG 1.7M
- Earning Date
- ARWR 11-25-2025
- HOG 10-23-2025
- Dividend Yield
- ARWR N/A
- HOG 2.68%
- EPS Growth
- ARWR N/A
- HOG N/A
- EPS
- ARWR N/A
- HOG 1.93
- Revenue
- ARWR $572,976,000.00
- HOG $4,474,610,000.00
- Revenue This Year
- ARWR $21,421.26
- HOG N/A
- Revenue Next Year
- ARWR N/A
- HOG $3.87
- P/E Ratio
- ARWR N/A
- HOG $13.96
- Revenue Growth
- ARWR 2816.20
- HOG N/A
- 52 Week Low
- ARWR $9.57
- HOG $20.45
- 52 Week High
- ARWR $39.42
- HOG $36.94
- Technical
- Relative Strength Index (RSI)
- ARWR 73.44
- HOG 37.64
- Support Level
- ARWR $36.29
- HOG $26.50
- Resistance Level
- ARWR $39.38
- HOG $29.22
- Average True Range (ATR)
- ARWR 1.39
- HOG 0.91
- MACD
- ARWR 0.06
- HOG -0.34
- Stochastic Oscillator
- ARWR 69.44
- HOG 7.26
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About HOG Harley-Davidson Inc.
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring segments, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 37% of the heavyweight domestic market in 2024.